“Increasing Integration of Egg Protein in Advanced Drug Formulations”
- The global egg protein in pharmaceuticals market is experiencing a notable trend toward the integration of egg white powder, egg yolk powder, and whole egg protein in advanced drug formulations
- These proteins, known for their high biological value and rich amino acid profiles, enable enhanced stability and functionality in pharmaceutical products, such as vaccines and biologics
- Egg proteins are being utilized for their binding, emulsifying, and stabilizing properties, which improve drug delivery systems and ensure consistent formulation quality
- For instance, several pharmaceutical companies are leveraging egg yolk powder as a natural emulsifier in oil-based vaccine formulations, while egg white powder is used in nutraceuticals for its high protein content and bioavailability
- This trend is enhancing the appeal of egg protein-based pharmaceuticals, making them more attractive to manufacturers seeking natural, high-quality ingredients
- Advanced processing techniques are being developed to analyze and optimize egg protein functionality, ensuring compatibility with diverse pharmaceutical applications
